Laurent Poirot

Company: Cellectis

Job title: Senior Vice President for Immunology

Seminars:

Multiplex TALEN Gene-Editing for the Next Generation of CAR-T Cells in Solid Tumors 10:30 am

Gene editing allows expanding the success of allogeneic CAR-T therapies in hematological malignancies to solid tumors Exploring various immune scenarios is needed depending on diseases/patient populations TALEN®-mediated highly efficient complex engineering allows programming of these immune scenarios into allogeneic CAR-T cells to optimize persistence, potency, and safetyRead more

day: Day Two

Panel Discussion: Leveraging Different Cell Types to Create More Controllable Cell Therapies 1:30 pm

Identifying the characteristics of the more traditional and emerging cell types used in cell therapy and discussing their pros and cons Mapping out how novel engineering approaches can help combine the therapeutic effect of each cell type Sharing effective assays and cell processing procedures to quantify therapeutic impactRead more

day: Day 1 - Track B - Lunch